Congenital Generalized Lipodystrophy: A Multisystemic Metabolic Disorder
Journal Title: International Journal of Clinical Endocrinology and Metabolism - Year 2016, Vol 2, Issue 1
Abstract
Introduction: Congenital generalized lipodystrophy or Berardinelli-Seip syndrome is a rare autosomal recessive multisystem disorder characterized by the near absence of subcutaneous and visceral adipose tissue from birth or early infancy with severe insulin resistance. It is caused by mutations in the gene for AGPAT-2 on chromosome 9 or BSCL-2/Seipin on chromosome 11 resulting in triglyceride-depleted adipocytes. BSCL-2/Seipin is a cell autonomous regulator of lipolysis essential for adipocyte differentiation.
Authors and Affiliations
Tewari Vishal V, Meht Ritu
Keywords
Related Articles
- EP ID EP541998
- DOI 10.17352/ijcem.000013
- Views 60
- Downloads 0
Childhood Gynecomastia: A Mini Review
Gynecomastia, referred to enlargement of the male’s breast tissue is a common finding in boys during childhood. Although most cases are benign and self-limited, it may be a sign of an underlying systemic disease or even...
60-Year-Old Man with Pheochromocytoma and Clinical Picture of Depression
Introduction: Pheochromocytoma is an adrenal gland tumour, which usually produces catecholamines. The classical triad of clinical symptoms consists of palpitations, headaches and profuse sweating. Other symptoms include:...
Metabolic Effects of D-Chiro-Inositol and Myo-Inositol in Polycystic Ovary Syndrome
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. The pathogenesis has not been fully deciphered. PCOS is associated with insulin resistance (IR), menstrual irregulariti...
An Analytical Study for Early Diagnosis and Treatment of Infants & Children Suffering From Congenital Hypothyroidism in China
Objective: To study the clinical and laboratory characteristics of children suffering from congenital hypothyroidism in China. Method: 455 cases of congenital hypothyroidism infants were collected from 5 articles were p...
Dipeptidyl Peptidase IV Inhibitory Activity of Berberine and Mangiferin: An In Silico Approach
Background: Dipeptidyl peptidase-IV (DDP-IV) Inhibitors may represent single anti-diabetic drugs, the multiple actions of which may translate into demonstrable therapeutic benefits in diabetes. The marketed synthetic DPP...